Company Overview Image

Our Story

SignalChem Diagnostics was founded in 2018 as a subsidiary of SignalChem Lifesciences, a biotechnology company based in Richmond, British Columbia, Canada. Building on SignalChem Lifesciences’ long-standing expertise in protein engineering, enzyme development, and molecular biology, SignalChem Diagnostics was established to translate deep biochemical and assay development knowledge into practical diagnostic solutions.

From the beginning, our focus has been on bridging advanced molecular technologies with real-world testing needs, developing tools that deliver reliable results while remaining practical for routine and on-site use.

Where We Are Today

SignalChem Diagnostics’ raw materials for IVD manufacturing, spanning strategic portfolios such as CRISPR, isothermal amplification, and clinical chemistry, have positioned us as a provider of quality reagents that have been thoroughly validated.

Today, leveraging our manufacturing expertise, SignalChem Diagnostics focuses on the development of pathogen detection kits powered by CRISPR-based detection and isothermal amplification technologies. Our solutions are designed to deliver rapid, sensitive, and reliable detection without reliance on centralized laboratory infrastructure.

Our technology approach combines in-house enzyme synthesis, assay chemistry optimization, and integrated workflow design to support fast and accurate nucleic acid detection. This foundation enables the development of one-pot molecular detection workflows designed for streamlined sample-to-result performance.

Our product portfolio includes portable detection devices, ready-to-use molecular detection kits, and nucleic acid assays for plant health, agricultural pathogen detection, and cannabis testing applications. Flagship technologies such as the CRISPOT® Detection Device and CRISPR-enabled detection kits are designed to support rapid decision-making directly at the point of need.

Our manufacturing and development processes are supported by ISO-accredited facilities and rigorous quality control systems focused on enzyme activity, purity, stability, and nuclease-free performance to ensure reliable assay outcomes.

In addition to catalog products, we support partners through assay development and customization capabilities, helping translate molecular detection concepts into scalable diagnostic solutions.

Our Culture

SignalChem Diagnostics is driven by scientific rigor, collaboration, and practical innovation. Our team combines expertise across molecular biology, protein engineering, assay development, and diagnostics manufacturing to develop solutions designed for real-world use.

As a Canadian company, we value diversity, inclusion, and global collaboration. By bringing together scientists and professionals from diverse backgrounds, we foster an environment that supports creativity, technical excellence, and continuous improvement.

Vision

To be a leading provider of accessible molecular pathogen detection solutions that enable faster, more confident decisions in agriculture, plant health, and applied molecular diagnostics.

Mission

Our mission is to develop accurate, rapid, and accessible point-of-care diagnostic kits by combining CRISPR technology, isothermal amplification, and rigorous assay design, transforming advanced molecular diagnostics into practical tools for on-site pathogen detection.

Core Values

Core Values